VanEck Associates
BIO icon

VanEck Associates’s Bio-Rad Laboratories Class A BIO Stock Holding History

VanEck Associates’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-19,450
Closed -$5.42M – 1347
2026
Q1 		$5.42M Sell
19,450
-456
-2% -$131K ﹤0.01% 786
2025
Q4 		$6.03M Sell
19,906
-16,648
-46% -$5.19M 0.01% 728
2025
Q3 		$10.3M Sell
36,554
-3,700
-9% -$1.01M 0.01% 537
2025
Q2 		$9.71M Sell
40,254
-556,476
-93% -$132M 0.01% 494
2025
Q1 		$145M Sell
596,730
-126,741
-18% -$38.1M 0.19% 117
2024
Q4 		$238M Sell
723,471
-580,281
-45% -$197M 0.3% 82
2024
Q3 		$437M Buy
1,303,752
+644,530
+98% +$205M 0.55% 44
2024
Q2 		$180M Buy
+659,222
New +$192M 0.26% 102
2022
Q3 		– Sell
-1,813
Closed -$897K – 1388
2022
Q2 		$897K Sell
1,813
-201
-10% -$105K ﹤0.01% 813
2022
Q1 		$1.13M Buy
2,014
+525
+35% +$316K ﹤0.01% 811
2021
Q4 		$1.13M Buy
1,489
+232
+18% +$174K ﹤0.01% 825
2021
Q3 		$938K Buy
1,257
+88
+8% +$65.9K ﹤0.01% 821
2021
Q2 		$753K Buy
1,169
+47
+4% +$28.6K ﹤0.01% 848
2021
Q1 		$641K Buy
1,122
+48
+4% +$28.4K ﹤0.01% 817
2020
Q4 		$626K Buy
1,074
+716
+200% +$408K ﹤0.01% 750
2020
Q3 		$185K Buy
+358
New +$181K ﹤0.01% 828

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

VanEck Associates's BIO Position: Q2 2026 in Review

VanEck Associates sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2026, closing a stake of 19,450 shares — an estimated $5.42M sold.

VanEck Associates first reported a position in BIO in Q3 2020 and held it in 16 quarters. The position peaked at $437M in Q3 2024. 398 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • VanEck Associates reported no remaining Bio-Rad Laboratories Class A position as of Q2 2026 after selling out during the quarter.
  • VanEck Associates sold 19,450 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $5.42M.
  • VanEck Associates first reported a position in Bio-Rad Laboratories Class A in Q3 2020 and held it in 16 quarters.
  • VanEck Associates's Bio-Rad Laboratories Class A position peaked at $437M in Q3 2024.
  • 398 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.